Showing results (3431-3440 of 45,231) with videos related to
Sort By:
Pageof 4,524
Cancer Research|April 10, 1999
Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomasW S Samowitz, M D Powers, L N Spirio, et al.Cancer Research|April 10, 1999
Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3'-kinase and Akt/protein kinase BJ P Carson, G Kulik, M J WeberCancer Research|April 10, 1999
Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccineL D Anderson, D Petropoulos, L A Everse, et al.Cancer Research|April 10, 1999
Cells deficient in DNA polymerase beta are hypersensitive to alkylating agent-induced apoptosis and chromosomal breakageK Ochs, R W Sobol, S H Wilson, et al.Cancer Research|April 10, 1999
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapyM G Steffens, O C Boerman, W J Oyen, et al.Cancer Research|April 10, 1999
Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinaseM Tan, R Grijalva, D YuCancer Research|April 10, 1999
Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathwayD Q Zheng, A S Woodard, M Fornaro, et al.Cancer Research|May 8, 1999
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumorsS J Advani, S M Chung, S Y Yan, et al.Cancer Research|May 8, 1999
Elevation of alpha2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitorsW Du, P F Lebowitz, G C PrendergastCancer Research|May 8, 1999
The pathway regulating MDM2 protein degradation can be altered in human leukemic cellsY Pan, D S HainesPageof 4,524